Drupal.behaviors.print = function(context) {window.print();window.close();}>
Santaris, Miragen Expand microRNA Partnership to Include Additional Targets
January 10, 2013
Santaris, Miragen Expand microRNA Partnership to Include Additional Targets
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
In 2012, Top microRNA Drug Developers Pull in Nearly $150M in Funding
December 20, 2012 / Gene Silencing News
Mirna Closes $34.5M Series C Round as microRNA Drugs Gain Investor Interest
October 25, 2012 / Gene Silencing News
Regulus Inks microRNA Drugs Collaboration with AstraZeneca
August 16, 2012 / Gene Silencing News
As Evidence Grows for Role of microRNAs in Disease, Drugmakers Focus on Select Targets
December 16, 2010 / Gene Silencing News
People in the News: Aimee Jackson, Christopher Morl, Stelios Papadopoulos, Olivier Voinnet
June 13, 2013 / Gene Silencing News